Neuroblastoma-An Overview of Laboratory Studies Aimed at Inducing Tumor Regression by Initiation of Differentiation or Administration of Antitumor Drugs

References

• Prasad K N. Maturation of neuroblastoma. Prolonged Arrest of Cancer, New Horizons in Oncology, BA Stoll. John Wiley, ChicesterUK 1982; Vol. 1: 281–308
   Google Scholar
• Murray M R, Stout A P. A sympathetic ganglioneuroma cultivated in vitro. Cancer 1948; 1: 242–247
   Google Scholar
• Simone J V, Cassady J R, Filler R M. Cancers of childhood. Principles and Practice of Oncology, VT DeVita, S Hellman, SA Rosenberg. JB Lippincott, Philadelphia 1982; 1254–1330
   Google Scholar
• Finklestein J Z, Tittle K, Meshnik R. Murine blastoma: Further evalution of the C1300 model with single antitumor agents. Cancer Chemother Rep 1975; 59: 975–983
   Google Scholar
• Finklestein J Z, Tittle K, Rubenstein J. Combination chemotherapy in murine neuroblastoma. Med Ped Oncol 1976; 2: 279–289
   Google Scholar
• Hill B T, Whelan R DH. Assessments of the sensitivities of cultured human neuroblastoma cells to antitumor drugs. Pediatr Res 1981; 15: 1117–1122
   Google Scholar
• Harlow P J, Siegel M M, Siegel S E. Antitumor activity of chemotherapeutic agents alone or in combination using a human neuroblastoma model system. Advances in Neuroblastoma Research, AE Evans. Raven Press, New York 1980; 319–325
   Google Scholar
• Siegel M M, Chung H S, Rucker N. In vitro and in vivo preclinical studies of human neuroblastoma. Cancer Treat Rep 1980; 64: 975–979
   Google Scholar
• Helson L. Animal models in pediatric cancer. Neuroblastoma. Neuroblastoma-Clinical and Biological Manifestations, C Pochedly. Elsevier Biomedical, New York 1982; 233–244
   Google Scholar
• Salmon S E, Meyskens F L, Alberts D S. New drugs in ovarian cancer and malignant melanoma: In vitro phase II screening with the human tumor stem cell assay. Cancer Treat Rep 1981; 65: 1–12
   PubMedGoogle Scholar
• Bottenstein J E. Differentiated properties of neuronal cell lines. Functionally Differentiated Cell Lines, G. Sato. Alan R. Liss, New York 1981; 155–184
   Google Scholar
• DeLatt S W, Van der Saag P T. The plasma membrane as a regulatory site in growth and differentiation of neuroblastoma cells. Int Rev Cytol 1982; 74: 1–5
   Google Scholar
• Bear M P, Schneider F H. The effects of actinomycin D and cordycepin on neurite formation and acetylcholinesterase activity in mouse neuroblastoma cells. Exp Cell Res 1979; 123: 301–309
   Google Scholar
• Yoda K, Fujimura S. Induction of differentiation in cultured mouse neuroblastoma cells by N-methyl-N′-nitro-N-nitrosoguanidine. Biochem Biophys Res Commun 1979; 87: 128–134
   Google Scholar
• Nishihira T, Kasai M, Hayashi Y. Experimental studies of differentiation of cells originated from human neural crest tumors in vitro and in vivo. Cell Mol Biol 1981; 27: 181–196
   Google Scholar
• Rupniak H T, Rein G, Powell J F. Characteristics of a new human neuroblastoma cell line which differentiates in response to cyclic-AMP. Cancer Res 1984; 44: 2600–2607
   Google Scholar
• Reynolds P, Reynolds D A, Smith R G. Dibutyryl cyclic AMP resistant neuroblastoma differentiates in response to bromodeoxyuridine. Proc Am Assoc Cancer Res 1981; 22: 46
   Google Scholar
• Littaner U Z, Giovanni M Y, Glick M C. Differentiation of human neuroblastoma cells in culture. Biochem Biophys Res Commun 1979; 88: 933–939
   Google Scholar
• Schengrund C-L, Scheffler B A. Biochemical and morphological study of adriamycin-induced changes in murine neuroblastoma cells. Oncology 1982; 39: 185–190
   PubMed Web of Science ®Google Scholar
• Rupniak H T. Unpublished data
   Google Scholar
• Goldstein M N, Plurad S. Drug-induced differentiation of human neuroblastoma: Transformation into ganglion cells with mitomycin C. Differentiation and Neoplasia, RG McKinnel, MA Di Bernardino, M Blumenfeld, RD Bergad. Springer-Verlag, Berlin 1980; 259–264
   Google Scholar
• Anderson D W, Crowle A G. Regression and differentiation of neuroblastoma tumors in mice treated with differentiating agents-prostaglandin E1 and a phosphodiesterase inhibitor, RO 20–1724. Cancer Lett 1982; 16: 287–295
   Google Scholar
• Lazo J S, Ruddon R W. Neurite extension and malignancy of neuroblastoma cells after treatment with prostaglandin E, and papaverine. JNCI 1977; 59: 137–143
   Google Scholar
• Sandquist D, Black A C. Reduced tumorigenicity of cultured neuroblastoma cells after treatment in vitro with dexamethasone. Eur J Cancer Clin Oncol 1982; 18: 1107–1115
   Google Scholar
• Wajsman Z, Williams P, Murphy O P. A study of the effect of papaverine in neuroblastoma using the experimental C-1300 murine system. Oncology 1978; 35: 1–4
   Google Scholar
• Helson L, Helson C, Peterson R F. A rationale for the treatment of metastatic neuroblastoma. JNCI 1976; 57: 727–729
   PubMedGoogle Scholar
• Tebbi C K, Chervinsky D, Weppner D. Interferon has a significant effect on neuroblastoma: An in vitro and in vivo study. Proc Am Assoc Cancer Res 1983; 24: 191
   Google Scholar
• Hill B T, Wheian R DH, Rupniak H T. A comparative assessment of the in vitro effects of drugs on cells by means of colony assays or flow microfiuorimetry. Cancer Chemother Pharmacol 1981; 7: 21–26
   PubMedGoogle Scholar
• Rupniak H T, Dennis L Y, Hill B T. An intercomparison of in vitro assays for assessing cytotoxicity after a 24 hour exposure to anticancer drugs. Tumori 1983; 69: 37–42
   Google Scholar
• Prasad K N, Sinha P K, Ramanujam M. Sodium ascorbate potentiates the growth inhibitory effect of certain agents on neuroblastoma cells in culture. Proc Natl Acad Sci USA 1979; 76: 829–832
   PubMed Web of Science ®Google Scholar
• Helson L, Helson C, Das S K (1978) Biochemistry and chemotherapy of human neural tumors in nude mice. Proceedings of the Symposium on the Use of Athymic (Nude) Mice in Cancer Research. 1978, DP Houchens, AA Overjera. Gustav Fischer, New York, 257–266
   Google Scholar
• Helson L. The nude mouse model for rational therapy. Advances in Neuroblastoma Research, AE Evans. Raven Press, New York 1980; 309–318
   Google Scholar
• Tsuchida Y, Kaneko Y, Kanda N. Possible relationship of chromosome abnormalities and gene amplification with effects of chemotherapy: A neuroblastoma xenograft study. Advances in Neuroblastoma Research, AE Evans, GJ D'Angio, RC Seeger. Alan R Liss, New York 1985; 171–180
   Google Scholar
• Biedler J L, Meyers M B, Spengler B A. Homogeneously staining regions and double minute chromosomes: Prevalent cytogenetic abnormalities of human neuroblastoma cells. Adv Cell Neurobiol 1983; 4: 267–307
   Google Scholar
• Danon Y L, Epstein M B, Siegel M M. Variability in DNA distributions of human neuroblastomas after cyclophosphamide. Cancer Treat Rep 1980; 64: 1275–1281
   Google Scholar
• Bruce W R, Meeker B E, Valeriote F A. Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo. JNCI 1966; 37: 233–245
   PubMedGoogle Scholar
• Hill B T. Cancer chemotherapy: The relevance of certain concepts of cell cycle kinetics. Biochim Biophys Acta 1978; 516: 389–417
   PubMed Web of Science ®Google Scholar
• Hill B T, Price L A. An experimental biological basis for increasing the therapeutic index of clinical cancer therapy. Ann NY Acad Sci 1982; 397: 72–87
   Google Scholar
• Salmon S E, Hamburger A W, Soehnlen B. Quantitation of differential sensitivity of human tumor stem cells to anticancer drugs. N Engl J Med 1978; 298: 1321–1327
   PubMed Web of Science ®Google Scholar
• Von Hoff D D, Casper J, Bradley E. Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy. Am J Med 1981; 70: 1027–1032
   PubMed Web of Science ®Google Scholar
• Von Hoff D D, Casper J, Bradley E. Direct cloning of human neuroblastoma cells in soft agar culture. Cancer Res 1980; 40: 3591–3597
   PubMedGoogle Scholar
• Bernal S, Thompson R, Gilbert F. In vitro and in vivo growth characteristics of two different cell populations in an established line of human neuroblastoma. Cancer Res 1983; 43: 1256–1260
   PubMedGoogle Scholar
• Ross R A, Spengler B A, Biedler J L. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. JNCI 1983; 71: 741–749
   PubMed Web of Science ®Google Scholar
• Emanuel B S, Balaban G, Boyd J P. N-myc amplification in multiple homogeneously staining regions in two human neuroblastomas. Proc Natl Acad Sci USA 1985; 82: 3736–3740
   PubMed Web of Science ®Google Scholar
• Hayes F A, Green A A, Casper J. Clinical evaluation of sequentially scheduled cisplatin and VM26 in neuroblastoma. Cancer 1981; 48: 1715–1718
   PubMedGoogle Scholar
• Reynolds P, Frenkel E P, Smith R G. Growth characteristics of neuroblastoma in vitro correlate with patient survival. Trans Assoc Am Phys 1980; XCIII: 203–211
   Google Scholar